Trial of Cost-Effective Assessment Should Be Postponed Until FY2016 at Earliest: Expert Subcommittee

The Central Social Insurance Medical Council’s (Chuikyo) Expert Subcommittee on Cost-Effective Assessments (chairman: Takeo Sekihara, managing director, Japan Cancer Society) decided at a meeting on December 25 that the cost-effective assessment of drugs and medical devices will not be introduced...read more